Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Recommendation of “Buy” by Analysts

Molina Healthcare, Inc. (NYSE:MOH) has been assigned an average rating of “Buy” from the sixteen ratings firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $160.25.

A number of equities research analysts have recently issued reports on MOH shares. Morgan Stanley upgraded shares of to an “overweight” rating and set a GBX 400 ($5.23) target price on the stock in a research note on Friday. Bank of America lowered shares of Genesee & Wyoming from a “neutral” rating to an “underperform” rating and set a $88.65 target price on the stock. in a research note on Tuesday, April 30th. Wells Fargo & Co set a $12.00 target price on shares of Infosys and gave the company a “hold” rating in a research note on Friday, May 31st. Barclays set a $145.00 target price on shares of Sanderson Farms and gave the company a “hold” rating in a research note on Friday, May 31st. Finally, BMO Capital Markets set a C$106.00 target price on shares of FirstService and gave the company a “market perform” rating in a research note on Monday, June 3rd.

In related news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $126.30, for a total transaction of $126,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel Cooperman sold 4,004 shares of the business’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $155.00, for a total transaction of $620,620.00. Following the sale, the director now directly owns 4,096 shares of the company’s stock, valued at approximately $634,880. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,304 shares of company stock valued at $945,495. Insiders own 0.77% of the company’s stock.

Several large investors have recently made changes to their positions in MOH. Parallel Advisors LLC grew its position in shares of Molina Healthcare by 97.9% during the 1st quarter. Parallel Advisors LLC now owns 186 shares of the company’s stock valued at $26,000 after buying an additional 92 shares during the last quarter. Cornerstone Advisors Inc. grew its position in shares of Molina Healthcare by 3,577.8% during the 1st quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock valued at $47,000 after buying an additional 322 shares during the last quarter. FTB Advisors Inc. grew its position in shares of Molina Healthcare by 367.6% during the 1st quarter. FTB Advisors Inc. now owns 346 shares of the company’s stock valued at $48,000 after buying an additional 272 shares during the last quarter. Financial Gravity Wealth Inc. bought a new stake in shares of Molina Healthcare during the 1st quarter valued at about $54,000. Finally, Quadrant Capital Group LLC grew its position in shares of Molina Healthcare by 289.3% during the 1st quarter. Quadrant Capital Group LLC now owns 545 shares of the company’s stock valued at $71,000 after buying an additional 405 shares during the last quarter.

MOH stock traded up $1.54 during trading on Friday, reaching $144.87. The stock had a trading volume of 370,648 shares, compared to its average volume of 513,483. The firm has a market capitalization of $8.98 billion, a P/E ratio of 13.07, a P/E/G ratio of 0.99 and a beta of 1.28. The company has a fifty day moving average of $144.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.57 and a quick ratio of 1.57. Molina Healthcare has a 1-year low of $101.87 and a 1-year high of $159.00.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Monday, April 29th. The company reported $3.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.41 by $0.63. The business had revenue of $4.12 billion for the quarter, compared to analyst estimates of $4.07 billion. Molina Healthcare had a net margin of 4.35% and a return on equity of 49.21%. The company’s revenue for the quarter was down 11.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.26 EPS. On average, research analysts expect that Molina Healthcare will post 10.96 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Featured Story: What is a stock buyback?

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.